Search results
Results from the WOW.Com Content Network
Article processing fees for journals indexed in the Directory of Open Access Journals (2019). Journals use a variety of ways to generate the income required to cover publishing costs (including editorial costs, any costs of administering the peer review system), such as subsidies from institutions [7] and subscriptions.
Both the relative risk and odds ratio are relevant in retrospective cohort studies, but only the odds ratio can be used in case-control studies. Although most case-control studies are retrospective, they can also be prospective when the researcher still enrolls participants based on the occurrence of a disease as new cases occur. [citation needed]
Clinical Rheumatology is a peer-reviewed medical journal covering rheumatology. It is published by Springer Science+Business Media on behalf of the International League of Associations of Rheumatology .
Journal of Clinical Rheumatology is a peer reviewed and indexed medical journal in the field of clinical rheumatology, published by PANLAR, Panamerican League of Associations for Rheumatology. [ 1 ] References
Best Practice & Research: Clinical Rheumatology is a medical journal covering evidence-based medicine as applied to clinical practice of musculoskeletal conditions. It is aimed at clinical physicians and trainees, to help them keep up to date with current practice. Issues contain review articles with a practical bent. [1]
The journal was established in 2006 by Future Medicine under the title Future Rheumatology. It became International Journal of Clinical Rheumatology in 2009 and is now published by Open Access Journals , an imprint of the Pulsus Group , which is on Jeffrey Beall 's list of "Potential, possible, or probable" predatory open-access publishers ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Juniper Publishers was listed in Beall's List of potential predatory open-access publishers. [3] The company has been criticized for sending out email spam to scientists, calling for papers, [11] [12] [13] and for publishing at least one paper that violated research integrity (missing conflict of interest statement, missing informed consent by patients, and plagiarism).